Various vasoconstrictors have shown promising results in the management of type 1 hepatorenal
syndrome (HRS). However, there are very few studies on vasopressors in the management of type
2 HRS. Terlipressin has been used commonly; however it is costly and not available in some
countries. In the present study, the investigators evaluated safety and efficacy of
terlipressin and noradrenaline in the treatment of type 2 HRS
Phase:
Phase 3
Details
Lead Sponsor:
Postgraduate Institute of Medical Education and Research